Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials

Clinical Trials

Akebia Therapeutics completes enrollment in its Phase IIb clinical study of AKB-6548 Akebia Therapeutics, a biopharmaceutical company, has completed enrollment in its ongoing 200-patient Phase IIb study of AKB-6548 for the treatment of anemia associated with chronic kidney disease (CKD) in patients who are not dependent on dialysis.
Contract Research & Services > Clinical Trials > News
Dendreon to present long-term Phase II STAND study at EAU congress Dendreon has announced the presentation of preliminary data from a long-term analysis of the Phase II STAND study demonstrating that tumor-specific T-cell responses appear to be enhanced and sustained when Provenge (sipuleucel-T) is given after androgen deprivation therapy (ADT) in patients with biochemically-recurrent prostate cancer (BRPC) at high risk for metastases.
Contract Research & Services > Clinical Trials > News Coronado starts investigator-initiated trial of TSO in pediatric patients with ASD By PBR Staff Writer
US-based Coronado Biosciences (CNDO) has started an investigator-initiated trial evaluating TSO (Trichuris suis ova or CNDO-201) for the treatment of pediatric patients with autism spectrum disorder (ASD).
Contract Research & Services > Clinical Trials > News
See more Clinical Trials news

Latest Clinical Trials News and Insight

View all Clinical Trials news or find news targeted to your interests
Dendreon to present long-term Phase II STAND study at EAU congress
Dendreon has announced the presentation of preliminary data from a long-term analysis of the Phase II STAND study demonstrating that tumor-specific T-cell responses appear to be enhanced and sustained when Provenge (sipuleucel-T) is given after androgen deprivation therapy (ADT) in patients with biochemically-recurrent prostate cancer (BRPC) at high risk for metastases.
Contract Research & Services > Clinical Trials > News
Woodley Equipment Announces the Appointment of Claire Lever
Woodley Equipment Company is pleased to announce the appointment of Claire Lever as Account Manager in our clinical trials division. Claire has experience of providing high quality customer service gained from working in similar account manager roles.
Contract Research & Services > Clinical Trials > Press Releases
Coronado starts investigator-initiated trial of TSO in pediatric patients with ASD
By PBR Staff Writer
US-based Coronado Biosciences (CNDO) has started an investigator-initiated trial evaluating TSO (Trichuris suis ova or CNDO-201) for the treatment of pediatric patients with autism spectrum disorder (ASD).
Contract Research & Services > Clinical Trials > News
Theravance begins Phase IIb trial of TD-4208 to treat COPD
By PBR Staff Writer
Theravance has initiated the dose-ranging Phase IIb trial 0117 of its investigational inhaled long-acting muscarinic antagonist (LAMA), TD-4208 as a nebulized aqueous solution in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Contract Research & Services > Clinical Trials > News
Helix begins enrollment in Polish Phase I/II trial of lung cancer drug candidate
By PBR Staff Writer
Canada-based biopharmaceutical firm Helix BioPharma has started enrolling patients for the eighth dose level cohort in its ongoing Phase I/II clinical safety, tolerability and preliminary efficacy trial of its drug candidate L-DOS47 in Poland for the treatment of lung cancer.
Contract Research & Services > Clinical Trials > News
Prothena starts Phase I trial of PRX002 to treat Parkinson's disease
By PBR Staff Writer
Ireland-based biotechnology firm Prothena has initiated dosing patients in a Phase I clinical trial of its therapeutic monoclonal antibody candidate targeting α-synuclein PRX002, to treat Parkinson's disease (PD).
Contract Research & Services > Clinical Trials > News
CROMSOURCE - Full International CRO
CROMSOURCE is an ISO-certified International provider of outsourced services to the pharmaceutical, biotechnology and medical device industries, specialized in clinical development and staffing solutions.
Contract Research & Services > Clinical Trials > Suppliers
Arno starts enrolling patients in Phase I/II trial of onapristone to treat prostate cancer
By PBR Staff Writer
Arno Therapeutics (ARNI), a US-based biopharmaceutical company, has initiated enrolling patients in a Phase I/II trial (NCT02049190) evaluating its lead compound 'onapristone' in men with advanced castration-resistant prostate cancer (CRPC) after failure of abiraterone or enzalutamide.
Contract Research & Services > Clinical Trials > News
Durbin - Comparator and Ancillary Supply for Clinical Trials
Durbin combines its heritage of over 45 years of sourcing and distributing specialist pharmaceuticals around the world with a commitment to partnership, working to bring a real difference to the provision of clinical trial comparators and ancillaries.
Contract Research & Services > Clinical Trials > Suppliers
Pfizer releases positive PALOMA-1 trial results of breast cancer combination drug
By PBR Staff Writer
Pfizer has reported positive results of its PALOMA-1 study, a randomised Phase II trial of palbociclib (PD-0332991) in combination with letrozole to treat breast cancer.
Contract Research & Services > Clinical Trials > News
View all Clinical Trials news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250